Adagrasib is a, targeting the KRAS G12C mutation in NSCLC. It’s specifically made to hit that mutated KRAS stuff that’s causing trouble in NSCLC with those G12C mutations. The med comes in these 200 mg pill things.
You’re supposed to take 600 mg of it twice a day, and it doesn’t matter if you eat or not before you pop the pill. Each bottle’s got 180 of these tabs, and it’s a big deal for people with NSCLC. Adagrasib is super important for tackling this disease, it stops that funky KRAS protein from doing its cancer thing.
It’s key that NSCLC folks take the med as directed to get the best results. Taking 600 mg twice a day keeps the drug level just right to fight that G12C mutation.
Reviews
There are no reviews yet.